<DOC>
	<DOCNO>NCT00884182</DOCNO>
	<brief_summary>This study part effort develop effective vaccination program child event pandemic . Study objective : - To describe safety profile period follow vaccination subject receive different vaccination schedule . - To describe immune response vaccination subject receive study vaccine .</brief_summary>
	<brief_title>Safety Immunogenicity Intramuscular A/H5N1 Inactivated , Split Virion Pandemic Influenza Vaccine Children</brief_title>
	<detailed_description>Study participant receive two administration investigational vaccine one 3 vaccination schedule .</detailed_description>
	<mesh_term>Infection</mesh_term>
	<mesh_term>Communicable Diseases</mesh_term>
	<mesh_term>Influenza , Human</mesh_term>
	<mesh_term>Orthomyxoviridae Infections</mesh_term>
	<mesh_term>Vaccines</mesh_term>
	<criteria>Inclusion Criteria : All Subjects Subject parent ( ) /legal representative able attend schedule visit comply trial procedure . Completion vaccination accord national immunization schedule Subjects Aged ≥ 2 Years &lt; 18 Years : Aged ≥ 2 year &lt; 18 year day inclusion . Provision Informed Consent Form sign subject 's parent ( ) /legal representative ( independent witness require local regulation ) . In addition , provision Assent Form sign subject age 8 11 year , Informed Consent Form sign subject ≥ 12 year . For female childbearing potential , avoid become pregnant ( use effective method contraception abstinence ) least 4 week prior vaccination , least 4 week vaccination . Subjects Aged ≥ 6 Months &lt; 2 Years : Aged ≥ 6 month &lt; 2 year day inclusion . Born full term pregnancy ( ≥ 37 week ) birth weight ≥ 2.5 kg . Provision Informed Consent Form sign parent ( ) legal representative ( independent witness require local regulation ) . Exclusion Criteria : All subject Participation another clinical trial investigate vaccine , drug , medical device , medical procedure 4 week precede trial vaccination Planned participation another clinical trial present trial period Known suspect congenital acquire immunodeficiency , immunosuppressive therapy anticancer chemotherapy radiation therapy within precede 6 month , longterm systemic corticosteroid therapy Known systemic hypersensitivity vaccine component history lifethreatening reaction trial vaccine vaccine contain substance Chronic illness , stage could interfere trial conduct completion , opinion investigator Current alcohol abuse drug addiction may interfere subject 's ability comply trial procedure Receipt Blood bloodderived product past 3 month , might interfere assessment immune response Receipt vaccine 4 week precede trial vaccination Planned receipt vaccine 4 week follow trial vaccination ( Known ) Human Immunodeficiency Virus ( HIV ) , Hepatitis B surface ( HBs ) antigen Hepatitis C seropositivity Previous vaccination avian influenza either trial vaccine another vaccine Thrombocytopenia , bleed disorder anticoagulant 3 week precede inclusion contraindicate IM vaccination Subjects deprive freedom administrative court order , emergency setting , hospitalize without his/her consent Received oral inject antibiotic therapy within 72 hour prior blood draw Subjects Aged ≥2 Years &lt; 18 Years : For female childbearing potential , known pregnancy positive urine pregnancy test Breastfeeding female Febrile illness ( temperature ≥ 37.5 °C ) moderate severe acute illness/infection day vaccination , accord investigator judgment Subjects Aged ≥ 6 Months &lt; 2 Years : History seizure Febrile illness ( temperature ≥ 38 °C ) moderate severe acute illness/infection day vaccination , accord investigator judgment .</criteria>
	<gender>All</gender>
	<minimum_age>6 Months</minimum_age>
	<maximum_age>17 Years</maximum_age>
	<verification_date>January 2014</verification_date>
	<keyword>Influenza</keyword>
	<keyword>Orthomyxoviruses</keyword>
	<keyword>Split Virion Pandemic Influenza Vaccine</keyword>
	<keyword>A/H5N1</keyword>
</DOC>